Medical News

RSS

Data shows frequent heartburn associated with cancers of the throat, vocal cord

Frequent heartburn was positively associated with cancers of the throat and vocal cord among nonsmokers and nondrinkers, and the use of antacids, but not prescription medications, had a protective effect, according to data published in Cancer Epidemiology, Biomarkers & Prevention, a journal of the American Association for Cancer Research.

24 May 2013

Bicycle helmet laws lead to 20% decrease in deaths and injuries, researchers find

Existing research shows that bicyclists who wear helmets have an 88 percent lower risk of brain injury, but researchers at Boston Children's Hospital found that simply having bicycle helmet laws in place showed a 20 percent decrease in deaths and injuries for children younger than 16 who were in bicycle-motor vehicle collisions.

24 May 2013

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Today the U.S. Food and Drug Administration announced that it is allowing marketing of the COBAS INTEGRA 800 Tina-quant HbA1cDx assay (Tina-quant HbA1cDx assay) for the diagnosis of diabetes by health care professionals.

24 May 2013

Wisconsin scientists synthesize potent compounds to curb bacteria that cause staph infections

In an age when microbial pathogens are growing increasingly resistant to the conventional antibiotics used to tamp down infection, a team of Wisconsin scientists has synthesized a potent new class of compounds capable of curbing the bacteria that cause staph infections.

24 May 2013

Combination of EEG and fMRI leads to improved treatment of patients with epilepsy

New techniques in imaging of brain activity developed by Jean Gotman, from McGill University's Montreal Neurological Institute, and his colleagues lead to improved treatment of patients suffering from epilepsy.

24 May 2013

Most residents dissatisfied with quality of substance-abuse training, survey finds

A 2012 survey of internal medicine residents at Massachusetts General Hospital (MGH) - one of the nation's leading teaching hospitals - found that more than half rated the training they had received in addiction and other substance use disorders as fair or poor.

24 May 2013

Heart disease signs in newborns: an interview with Dr Michael Skilton, University of Sydney

Thickening of the walls of the main arteries is the best indicator of poor cardiovascular health in healthy young children.

23 May 2013

Lightlake Therapeutics announces Phase II clinical trial results of nasal spray treatment for BED

Lightlake Therapeutics Inc., a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that results of the Company's Phase II clinical trial of its nasal spray treatment for Binge Eating Disorder were presented at the American Psychiatric Association Annual Meeting in San Francisco by Professor Hannu Alho, MD, professor of addiction medicine at the University of Helsinki and Principal Investigator for the trial.

23 May 2013

HealthSouth plans to construct 50-bed inpatient rehabilitation hospital in Georgia

HealthSouth Corporation announced today that it plans to build a 50-bed comprehensive inpatient rehabilitation hospital in Newnan, Ga.

23 May 2013

Groundbreaking anti-aging dietary supplement

Jeunesse Global, a network marketing company that dedicates its research to promoting healthy and youthful living, has produced the solution to one of the fundamental causes of cellular aging.

23 May 2013

New data highlights urgent crisis posed on US healthcare system by DFUs and VLUs

Organogenesis Inc., a commercial leader in the field of regenerative medicine, presented new data generated in collaboration with a team of expert economists from Analysis Group (a leading health economics consultancy) demonstrating the significant healthcare resource and economic burden that diabetic foot ulcers and venous leg ulcers place upon the US healthcare system.

23 May 2013

Lund University researchers deactivate mutated huntingtin protein in the brains of mice

Researchers at Lund University have succeeded in preventing very early symptoms of Huntington's disease, depression and anxiety, by deactivating the mutated huntingtin protein in the brains of mice.

23 May 2013

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

Cenix BioScience, a leading preclinical contract research provider and technology developer specialized in RNAi-, miRNA- and high content-driven pharmacology, and Debiopharm Group, a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, including oncology and companion diagnostics, today announced that they have signed a research agreement to support Debiopharm in its ongoing efforts to develop novel therapeutic drug candidates.

23 May 2013

OncoGenex plans to initiate OGX-42 Phase 2 trial in patients with advanced squamous cell lung cancer

OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.

23 May 2013

Research project analyses practice of mediation in two public hospitals in Valencian Community

The research project from the Universitat Jaume I de Castellón (Spain) analyses the practice of mediation in two public hospitals in the Valencian Community through cases that involved a team of mediators over two years.

23 May 2013

FDA clears Omeros' OMS824 IND for treatment of Huntington's disease

Omeros Corporation today announced that its Investigational New Drug Application to evaluate OMS824 in Huntington's disease has been cleared by the U.S. Food and Drug Administration.

23 May 2013

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Celgene International Sàrl, a subsidiary of Celgene Corporation today announced that the U.S. Food and Drug Administration has assigned a Priority Review designation to the supplemental New Drug Application for the use of ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound) in combination with gemcitabine for the first-line treatment of patients with advanced pancreatic cancer.

23 May 2013

Market pressures may keep premiums low as health law kicks in

USA Today reports this optimisitic view is offered by some industry analysts and health insurance officials. Meanwhile, Politico does a status check on the legal challenges to the health law's birth control mandate. News reports also track the latest regarding the Internal Revenue Service controversy and the overhaul.

23 May 2013

DESolve bioresorbable coronary scaffold system safe and effective, shows low rates of late lumen loss

The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial reported at EuroPCR 2013 today.

23 May 2013

Researchers develop new guidelines to govern amount of blood ordered for surgical patients

Johns Hopkins researchers have developed new guidelines - the first in more than 35 years - to govern the amount of blood ordered for surgical patients.

23 May 2013

Medical News

Data shows frequent heartburn associated with cancers of the throat, vocal cord

Bicycle helmet laws lead to 20% decrease in deaths and injuries, researchers find

FDA approves Tina-quant HbA1cDx assay for diagnosis of diabetes

Wisconsin scientists synthesize potent compounds to curb bacteria that cause staph infections

Combination of EEG and fMRI leads to improved treatment of patients with epilepsy

Most residents dissatisfied with quality of substance-abuse training, survey finds

Heart disease signs in newborns: an interview with Dr Michael Skilton, University of Sydney

Lightlake Therapeutics announces Phase II clinical trial results of nasal spray treatment for BED

HealthSouth plans to construct 50-bed inpatient rehabilitation hospital in Georgia

Groundbreaking anti-aging dietary supplement

New data highlights urgent crisis posed on US healthcare system by DFUs and VLUs

Lund University researchers deactivate mutated huntingtin protein in the brains of mice

Cenix BioScience, Debiopharm partner to develop novel therapeutic drug candidates

OncoGenex plans to initiate OGX-42 Phase 2 trial in patients with advanced squamous cell lung cancer

Research project analyses practice of mediation in two public hospitals in Valencian Community

FDA clears Omeros' OMS824 IND for treatment of Huntington's disease

FDA gives Priority Review to Celgene's ABRAXANE sNDA for advanced pancreatic cancer

Market pressures may keep premiums low as health law kicks in

DESolve bioresorbable coronary scaffold system safe and effective, shows low rates of late lumen loss

Researchers develop new guidelines to govern amount of blood ordered for surgical patients

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News